الفهرس 
Chronic kidney disease
Mineral bone disordersOnly 14 pages are availabe for public view
 |  | from | 115 |  |  |
| | | from | 115 | | |
Abstract
Mineral Disturbance (BMD) is considered to be one of the major public health problems in patients with end stage renal disease on regular hemodialysis. CKD-MBD is defined as an alteration of bone morphology in patients with chronic kidney disease (CKD), patients with advanced renal failure and those treated with hemodialysis. The measurements of serum calcium, phosphorus, alkaline phosphatase levels and PTH are used to evaluate, diagnose, and guide the treatment. The two major disorders of bone disease in CKD are: high turnover hyper-parathyroid and low turnover bone disorders. Serum PTH level is considered an adequate screening tool to separate these two diseases. Measurement of serum parathyroid hormone (PTH) has long been considered the principal biochemical marker for diagnosis and monitoring therapy of renal bone disease. Nevertheless, there is a scarcity in the published literature regarding the prevalence of BMD in CKD patients. Therefore, we conducted the present study in order to study the prevalence of mineral bone disorders in CKD patients in Gharbia governorate. The present study was a cross-sectional, comparative, study that carried out from January 2018 to December 2019 at Tanta University Hospitals and Gharbia governmental and central hospitals. Patients with CKD presented to the outpatient clinics and inwards of Internal Medicine Departments and Nephrology units were recruited.